Cheng-Hsueh Tsai

机构：National Taiwan University Hospital

发表论文 6 篇 · 总被引 196 次 · h-index 4

代表论文

• Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base Editing (2020 · Molecular Therapy — Nucleic Acids · 被引 93)
• HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis (2020 · Journal of Hepatology · 被引 70)
• Hepatitis B surface antigen level identifies patients with inactive chronic hepatitis B from Asia with HCC risk below surveillance threshold (2025 · Gut · 被引 15)
• Downregulation of Methionine Cycle Genes MAT1A and GNMT Enriches Protein-Associated Translation Process and Worsens Hepatocellular Carcinoma Prognosis (2022 · International Journal of Molecular Sciences · 被引 14)
• Resistance-associated substitution and ledipasvir/sofosbuvir therapy in Mongolian chronic hepatitis C patients (2019 · Journal of the Formosan Medical Association · 被引 4)
• Glycine N-methyltransferase modulates mitochondria-derived formate utilization and central carbon metabolism during methotrexate therapy (2026 · Molecular Medicine)